In vitro activity of extracts from Polyporaceae against human immunodeficiency virus type 1

Phytotherapy Research

Volumn 10, Issue 6, 1996, Pages 497-503

  Walder, R ^a   Kalvatchev, Z ^a   Garzaro, D ^a   Barrios, M ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

antiviral activity; HIV 1; natural products; Polyporaceae

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DEXTRAN; FOSCARNET; INTERFERON; PLANT EXTRACT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL FUSION; CELL LINE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERFERON PRODUCTION; MOUSE; NONHUMAN; VENEZUELA; VESICULAR STOMATITIS VIRUS; VIRUS INACTIVATION; VIRUS REPLICATION;

EID: 0029850955     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199609)10:6<497::AID-PTR892>3.0.CO;2-V     Document Type: Article

References (30)

1. Atsumi, S., Umezawa, K., Iinuma, H. et al. (1990). Production, isolation and structure determination of a novel β-glucosidase inhibitor, cyclophellitol, from Phellinus sp. J. Antibiot. XLIII, (1), 49-53.
2. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., and De Clercq, E. (1988). Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl Acad. Sci. USA 85, 6132-6136.
3. Baba, M., Schols, D., Pauwels, R., Nakashima, H., and De Clerq, E. (1990). Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. J. AIDS 3, 493-499.
4. Capobianchi, M. R., De Marco, F., Di Marco, P., and Dianzani, F. (1988). Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells. Arch. Virol. 99, 9-19.
5. Familletti, P. C., Rubinstein, S., and Pestka, S. (1981). Convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol. 78, 387-394.
6. Gao, Q., Gu, Z., Parniak, M. A., Li, X., and Wainberg, M. S. (1992). In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3′-azido-3′-deoxythymidine and 2′, 3′-dideoxyinosine. J. Virol. 66, 12-19.
7. Haseltine, W. B. (1988). Replication and pathogenesis of the AIDS virus. J. AIDS 1, 217-240.
8. Havell, E. A. (1981). Production and quantitation of neutralizing antibodies for human fibroblast interferon. Methods Emzymol. 79, 571-575.
9. Ito, M., Nakashima, H., Baba, M. et al. (1987). Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV/LAV)]. Antiviral Res. 7, 127-137.
10. Itoh, W., Sugawara, I., Kimura, S. et al. (1990). Immunopharmacological study of sulfated schizophyllan (SPG) I. Its action as a mitogen and anti-HIV agent. Int. J. Immunopharmacol. 12, 225-233.
11. Kashman, Y., Gustafson, K. R., Fuller, R. W. et al. (1992). The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J. Med. Chem. 35, 2735-2743.
12. Kikukawa, R., Koyanagi, Y., Harada, S., Kobayashi, N., Hatanaka, M., and Yamamoto, N. (1986). Differential susceptibility to the Acquired immunodeficiency Syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J. Virol. 57(3), 1159-1162.
13. Klatzman, D., Champagne, E., Chamaret, S. et al. (1984). T-lymphocyte T4 molecule behaves as the receptor for human retroviral law. Nature 312, 767-768.
14. Lednicer, D., and Snader, K. M. (1990). Plants and other organisms as a source of anti-human immunodeficiency virus (HIV) drugs. In Economic and Medicinal Plant Research, vol. 5 Academic Press Ltd, pp. 1-20.
15. Lifson, J., Coutre, S., Huang, E., and Engleman, E. (1986). Role of envelope glycoprotein carbohydrate in human immuno-deficiency virus (HIV) infectivity and virus-induced cell fusion. J. Exp. Med. 164, 2101-2106.
16. Manfredi, K. P., Blunt J. W., Cardellina II, J. H. et al. Novel alkaloids from the tropical plants Ancistrocladus abbreviates inhibit cell killing by HIV-1 and HIV-2. J. Med. Chem. 34, 3402-3405.
17. McCloud, T. G., Nemec, J., Muschik, G. et al. (1988). Extraction of bioactive molecules from plants. Proc. Inter. Congress on Natural Products Research, Park City, Utah.
18. Merchant, D. J., Kahn, R. H., and Murphy. W. H. (1960). Handbook of Cell and Culture, p. 157. Burgess Publishing Co., Minneapolis.
19. + cells. Science 240, 646-649.
20. Mitsuya, H., Yarchoan, R., and Broder, S. (1990). Molecular targets for AIDS therapy. Science 249, 1533-1544.
21. Pal, R., DeVico, A., Rittenhouse, S., and Sarngadharan, M. G. (1993). Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by soluble CD4 and the lectin succinil Con A. Virology 194, 833-837.
22. Popovic, M., Sarngadharan, M. G., Read, E., and Gallo, R. C. (1984). Detection, isolation and continuous production of cytopathic retroviruses from patients with AIDS. Science 224, 497-500.
23. Reed, L. J., and H. Muench (1938). A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
24. Schols, D., Pauwells, R., Desmyter, J., and De Clercq, E. (1990). Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp 120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology 175, 556-561.
25. Sodroski, J., Goh, W. C., Rosen, C., Campbell, K., and Haseltine, W. A. (1986). Role of the HTLV-III/LAV envelope in syncytium formation and cytopathogenicity. Nature (London) 322, 470-474.
26. Van der Meide, P. H., Dubbeld, M., and Schellekens, H. (1985). Monoclonal antibodies to human immune Interferon and their use in a sensitive solid-phase ELISA. J. Immunol. Methods 79, 293-305.
27. Veronese, F. D., de Vico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., and Sarngadharam, M. G. (1985). Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229, 1402-1405.
28. + lymphocytes and cells infected by human immunodeficiency virus. Proc. Natl Acad. Sci. USA, 84, 1429-1433.
29. Zagury, D., Bernard, J., Leonard, R., Cheynier, R., Feldman, M., and Sarin, P. S. (1986). Long-term cultures of HTLV-III-infected T cells: a mode) of cytopathology of T-cell depletion in AIDS. Science 231, 850-853.
30. Zagury, J. F., Lachgar, A., Achour. A. et al. (1994). Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS. Biomed. Pharmacother. 48, 11-16.